The first GLP-1RA approved for obesity was liraglutide in 2014, under the name Saxenda, while a higher-dose version of semaglutide was approved under the name Wegovy in 2021
De Miguel E, Puig JG, Castillo C, et al
Patients using tirzepatide as part of a physician-led program may experience: Results depend on individual biology, adherence, and overall health
Florida : Broward County, Delray Beach, Ft
We trust semaglutide and terzepatide in our own personal health journeys as well
Mounjaro and Ozempic were initially sold as diabetes medications, while Wegovy is specifically for weight loss